1-4 of 4
Johannes M. F. G. Aerts
Close
Sort by
Journal Articles

Phenotype diversity in type 1 Gaucher disease: discovering the genetic basis of Gaucher disease/hematologic malignancy phenotype by individual genome analysis

Sarah M. Lo, Murim Choi, Jun Liu, Dhanpat Jain, Rolf G. Boot, Wouter W. Kallemeijn, Johannes M. F. G. Aerts, Farzana Pashankar, Gary M. Kupfer, Shrikant Mane, Richard P. Lifton, Pramod K. Mistry
Journal: Blood
Blood (2012) 119 (20): 4731–4740.
https://doi.org/10.1182/blood-2011-10-386862
Published: 2012
Journal Articles

Low-dose versus high-dose therapy for Gaucher disease: goals and markers

Carla E. M. Hollak, Maaike de Fost, Johannes M. F. G. Aerts, Stephan vom Dahl
Journal: Blood
Blood (2007) 109 (1): 387.
https://doi.org/10.1182/blood-2006-07-033233
Published: 2007
Journal Articles

Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis

Clinical Trials & Observations
Maaike de Fost, Carla E. M. Hollak, Johanna E. M. Groener, Johannes M. F. G. Aerts, Mario Maas, Ludger W. Poll, Maaike G. Wiersma, Dieter Häussinger, Sarah Brett, Nicole Brill, Stephan vom Dahl
Journal: Blood
Blood (2006) 108 (3): 830–835.
https://doi.org/10.1182/blood-2005-12-5072
Published: 2006
Journal Articles

Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention

Clinical Trials & Observations
Rolf G. Boot, Marri Verhoek, Maaike de Fost, Carla E. M. Hollak, Mario Maas, Boris Bleijlevens, Marielle J. van Breemen, Marjan van Meurs, Leonie A. Boven, Jon D. Laman, Mary Teresa Moran, Timothy M. Cox, Johannes M. F. G. Aerts
Journal: Blood
Blood (2004) 103 (1): 33–39.
https://doi.org/10.1182/blood-2003-05-1612
Published: 2004